Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
an upstream activator of PARP
35 μM against MDA-MB-468 and MCF-7 cells
Anti-breast cancer activity of LFM-A13
3-dichlorophenyl)thio)-4-nitrothiophen-2-yl)ethanone
) shows a marked
Cariprazine free base - CAS# 839712-12-8 size:10mg solid an upstream activator of PARPCariprazine free base, CAS No. 839712 12 8, also known as RGH 188 and MP 214, is an antipsychotic drug received FDA approval on September 17, 2015. Cariprazine acts as a D2 and D3 receptor partial agonist, with high selectivity towards the D3 receptor. Action on the dopaminergic systems makes it also potentially useful as an add on therapy in major depressive disorder. Cariprazine is approved for schizophrenia and bipolar disorder. It has also been
US$ 13.00
US$ 1479.50
US$ 7999.50